Search research articles
Contact Us
Filters
Showing results (81-90 of 272) with videos related to
Page
of 28
Sort By:
Therapeutic Advances in Rare Disease
|
July 22, 2025
Sparsentan in IgA nephropathy: a plain language summary of publication for the PROTECT study
Brad H Rovin, Radko Komers, Chris Scroggins, et al.
Lancet (London, England)
|
March 24, 2024
Unwelcome changes to the Specialised Foundation Programme recruitment
Jonathan Barratt, Debbie Sharp, Waljit S Dhillo, et al.
Clinical and Experimental Nephrology
|
February 14, 2019
New strategies and perspectives on managing IgA nephropathy
Haresh Selvaskandan, Chee Kay Cheung, Masahiro Muto, et al.
Kidney International
|
March 25, 2019
IgA nephropathy: "State of the art": a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description
Hernán Trimarchi, Jonathan Barratt, Renato C Monteiro, et al.
Seminars in Immunopathology
|
September 14, 2007
Immunopathogenesis of IgAN
Jonathan Barratt, Alice C Smith, Karen Molyneux, et al.
Journal of Nephrology
|
November 20, 2024
Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine
Mehmet Kanbay, Lasin Ozbek, Mustafa Guldan, et al.
Kidney International Reports
|
January 1, 2020
Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
Jonathan Barratt, Brad Rovin, Ulysses Diva, et al.
Seminars in Nephrology
|
September 5, 2018
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy
Jan Novak, Jonathan Barratt, Bruce A Julian, et al.
Kidney International
|
November 1, 2014
Evidence-based classification of glomerular pathology
Terry Cook, Ian S D Roberts, John Feehally, et al.
Contributions to Nephrology
|
May 15, 2007
International IgA nephropathy network clinico-pathological classification of IgA nephropathy
John Feehally, Jonathan Barratt, Rosanna Coppo, et al.
Page
of 28
Search research articles
Search
Showing results (81-90 of 272) with videos related to
Sort By:
Page
of 28
Therapeutic Advances in Rare Disease
|
July 22, 2025
Sparsentan in IgA nephropathy: a plain language summary of publication for the PROTECT study
Brad H Rovin, Radko Komers, Chris Scroggins, et al.
Lancet (London, England)
|
March 24, 2024
Unwelcome changes to the Specialised Foundation Programme recruitment
Jonathan Barratt, Debbie Sharp, Waljit S Dhillo, et al.
Clinical and Experimental Nephrology
|
February 14, 2019
New strategies and perspectives on managing IgA nephropathy
Haresh Selvaskandan, Chee Kay Cheung, Masahiro Muto, et al.
Kidney International
|
March 25, 2019
IgA nephropathy: "State of the art": a report from the 15th International Symposium on IgA Nephropathy celebrating the 50th anniversary of its first description
Hernán Trimarchi, Jonathan Barratt, Renato C Monteiro, et al.
Seminars in Immunopathology
|
September 14, 2007
Immunopathogenesis of IgAN
Jonathan Barratt, Alice C Smith, Karen Molyneux, et al.
Journal of Nephrology
|
November 20, 2024
Post-transplant IgA nephropathy: a rapidly evolving field of kidney transplant medicine
Mehmet Kanbay, Lasin Ozbek, Mustafa Guldan, et al.
Kidney International Reports
|
January 1, 2020
Implementing the Kidney Health Initiative Surrogate Efficacy Endpoint in Patients With IgA Nephropathy (the PROTECT Trial)
Jonathan Barratt, Brad Rovin, Ulysses Diva, et al.
Seminars in Nephrology
|
September 5, 2018
Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy
Jan Novak, Jonathan Barratt, Bruce A Julian, et al.
Kidney International
|
November 1, 2014
Evidence-based classification of glomerular pathology
Terry Cook, Ian S D Roberts, John Feehally, et al.
Contributions to Nephrology
|
May 15, 2007
International IgA nephropathy network clinico-pathological classification of IgA nephropathy
John Feehally, Jonathan Barratt, Rosanna Coppo, et al.
Page
of 28